CCL5 and myeloid sarcoma: As shown in Figure 3, we observed that patients with MS carrying the C allele, presented significantly higher CSF levels of TNF (TT patients median = 0.29, IQR = 0–1.03; CT/CC median = 1.15, IQR = 0.31–24.65; B-H adjusted p < 0.001), IL-5 (TT patients median = 0, IQR = 0–0.39; CT/CC median = 0.37, IQR = 0–27.33; B-H adjusted p < 0.001) and RANTES (TT patients median = 0.62, IQR = 0–6.72; CT/CC median = 49.97, IQR = 0.65–373.25; B-H adjusted p < 0.001).